Market Context — Why This Technology, Why Now

Consumers globally are increasingly prioritizing natural, 'clean label' ingredients for both health and beauty, driving significant growth in the functional food and cosmeceutical markets. This trend, coupled with rising awareness of preventive health and the desire for healthy aging, creates a strong market pull for innovative, safe, and effective natural compounds. Regulatory bodies are also becoming more receptive to science-backed functional ingredients, opening new avenues for product claims. This technology's dual action and natural origin position it perfectly to capitalize on these converging market forces, offering a competitive edge to companies seeking to differentiate their offerings.

Key Competitive Advantages
01

Offers extremely low side effect risk compared to synthetic drugs, as it is derived from Lactococcus lactic acid bacteria with a proven probiotic track record, making it suitable for long-term intake or use.

02

Provides potential blood pressure reduction through ACE inhibition, alongside anticipated skin anti-aging and wrinkle improvement effects, addressing multiple health and beauty needs with a single ingredient.

03

Eliminates the need for complex chemical synthesis by utilizing live cells, dead cells, or extracts, potentially reducing manufacturing costs and facilitating easy integration into existing food and cosmetic production lines.

Market Opportunity
Functional Food Market
$2.5B–$3.0B domestically (AI est.)
Growing consumer awareness of health longevity drives increased demand for foods promoting blood pressure management and anti-aging benefits, indicating continued market expansion.
Major food & beverage corporations Nutraceutical product developers Health supplement manufacturers
Anti-Aging Cosmetics Market
$1.5B–$2.0B domestically (AI est.)
Driven by the universal desire to maintain youthfulness and increasing interest in safe, naturally derived ingredients, this market shows significant anticipation for novel materials.
Global beauty and skincare brands Specialty cosmetic ingredient suppliers Dermatological product companies
Probiotics Market
$35B–$40B globally (AI est.)
Beyond gut health, there's growing focus on probiotics for immune enhancement and specific disease prevention, continuously expanding their application scope.
Pharmaceutical companies with probiotic divisions Functional dairy and fermented food producers Health and wellness product innovators
IP Defensibility — Why Competitors Can't Replicate This
What This Patent Covers

The patent was granted after successfully addressing examiner rejections with appropriate arguments and amendments, indicating a clearly defined and robust scope of rights. It specifically protects ACE inhibitors containing live cells, dead cells, or extracts of Lactococcus lactis N7 strain, along with their use in skin anti-aging and wrinkle improvement compositions.

Competitive White Space

This patent specifically covers the Lactococcus lactis N7 strain for ACE inhibition and skin aging. White space exists for exploring other probiotic strains with similar or complementary bioactivities, or for developing novel delivery systems that enhance the stability and efficacy of these compounds in specific applications.

Economic Impact
~$2.5M/year estimated new revenue from market penetration (est.)
estimated ROI · USD · AI analysis
ROI Calculation Logic

Estimates economic impact from developing functional foods or high-value cosmetics using this technology. Targeting the domestic functional food market (~$2.65B (AI est.)) and anti-aging cosmetics market (~$1.65B (AI est.)), assuming a 0.05% share for products applying this technology. This projects (~$2.65B + ~$1.65B)

× 0.05% = ~$2.0M/year (AI est.) in new revenue. Additionally, considering increased unit prices from enhanced value in existing products, annual sales growth could exceed ~$2.5M (AI est.).

Speed to Market
4× faster than in-house development
If developing this technology from scratch in-house, at least 4 years would be required for screening specific lactic acid bacteria strains, identifying active ingredients, elucidating mechanisms of action, and evaluating safety and efficacy. However, by licensing this patent, which already identifies the N7 strain, confirms its ACE inhibitory activity, and demonstrates its potential for skin anti-aging, this timeline can be significantly shortened. Specifically, by skipping the basic research phase and focusing on formulation development, manufacturing process optimization, and final product evaluation, market entry could be reduced to approximately 1 year.
Competitive Positioning

X: Safety and Natural Origin
Y: Multi-functionality and Efficacy Scope

Business Models & Applications
🥤 Functional Food & Beverage Development
Develop functional foods such as blood pressure care beverages, anti-aging supplements, and yogurts incorporating this technology, targeting health-conscious consumers.
✨ High-Value Cosmetics Development
Formulate this technology into serums, creams, and masks that claim skin anti-aging and wrinkle improvement effects, building natural and high-performance cosmetic brands.
🤝 Raw Material Supply & Licensing
Generate revenue by supplying the lactic acid bacteria-derived ACE inhibitor as a raw material to food and cosmetic manufacturers, or by licensing the technology.
Adjacent Application Opportunities
🐶 Pet Care & Animal Supplements
Pet Health Longevity Supplements
This technology could be applied to functional pet foods and supplements to support blood pressure management and skin/coat health for aging pets, addressing growing pet owner concerns. Its natural origin enhances consumer trust and appeal in a market projected to reach over $10 billion globally.
🏥 Medical Foods & Nutritional Therapy
Medical Food for Hypertension Management
Could be developed as a medical food for individuals with pre-hypertension or mild hypertension, potentially offered in collaboration with physicians and dietitians as part of nutritional therapy. Accumulating safety and efficacy data could facilitate its use in clinical settings, targeting a segment of the $50 billion global medical food market.
🔬 Research Reagents & Materials
Research Material for Pharma & Cosmetic Development
The N7 strain's cells or extracts could be supplied as research reagents for novel ingredient development in pharmaceutical and cosmetic industries. This could contribute to advancing basic research on ACE inhibition mechanisms and skin physiological activity, potentially opening new application fields with a market value exceeding $500 million for specialized biochemicals.
Integration Roadmap — Estimated 18-Month Deployment
Phase 1: Technology Evaluation & Product Concept Development
Duration: 3 months
Conduct a detailed evaluation of this technology and verify its suitability for the company's product portfolio. Clearly define target markets and product concepts, establishing the foundation for the business plan.
Phase 2: Prototyping & Safety/Efficacy Evaluation
Duration: 9 months
Develop prototypes based on the defined product concept. Conduct in-house safety and stability tests, along with third-party efficacy evaluations (e.g., human clinical trials) to gather data.
Phase 3: Manufacturing Process Establishment & Market Launch
Duration: 6 months
Establish a mass production process based on prototype evaluation results. Complete compliance with relevant regulations, develop and execute marketing strategies, and aim for product market introduction.
Technical Feasibility
This technology, utilizing live cells, dead cells, or extracts of Lactococcus lactis N7 strain as active ingredients, is technically easy to integrate into existing food and cosmetic manufacturing lines. It can be formulated in various forms, such as powders or liquids for existing products, or molded into capsules or tablets. Minimal new equipment investment is required, and existing microbial culture and extraction technologies can be applied, indicating low technical hurdles.
Success Scenario
Upon adopting this technology, licensees could build an innovative product lineup addressing both health longevity and beauty needs. For example, they may introduce functional foods marketed for 'gently lowering blood pressure for individuals with elevated blood pressure' or cosmetics for 'reducing the appearance of fine wrinkles caused by dryness.' This could enable clear differentiation from competitors, acquire new customer segments, and is estimated to expand new business division sales by over 20% within three years post-introduction.
Patent Record
APPLICATION NO.
特願2021-081054
REGISTRATION NO.
7646972
FILING DATE
2021/05/12
GRANT DATE
2025/03/10
EXPIRATION DATE
2041/05/12
PATENT HOLDER
国立研究開発法人農業・食品産業技術総合研究機構
Examination History
2024年02月02日
出願審査請求書
2025年01月07日
拒絶理由通知書
2025年01月09日
意見書
2025年01月09日
手続補正書（自発・内容）
2025年01月28日
特許査定